Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Maserati

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Infection|May 28, 2009
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER CohortsC Torti, G Lapadula, A Antinori, et al.
Infection|January 27, 2009
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patientsM M Santoro, A Bertoli, P Lorenzini, et al.
The Journal of Frailty & Aging|February 9, 2019
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected PersonsG Guaraldi, S Marcotullio, R Maserati, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2006
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)G Carosi, C Torti, M Andreoni, et al.
Infection|October 23, 2013
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study groupV Svicher, C Alteri, M Montano, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Infection|May 28, 2009
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER CohortsC Torti, G Lapadula, A Antinori, et al.
Infection|January 27, 2009
Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patientsM M Santoro, A Bertoli, P Lorenzini, et al.
The Journal of Frailty & Aging|February 9, 2019
The Management of Geriatric and Frail HIV Patients. A 2017 Update from the Italian Guidelines for the Use of Antiretroviral Agents and the Diagnostic Clinical Management of HIV-1 Infected PersonsG Guaraldi, S Marcotullio, R Maserati, et al.
The Journal of Antimicrobial Chemotherapy|April 12, 2006
Key questions in antiretroviral therapy: Italian Consensus Workshop (2005)G Carosi, C Torti, M Andreoni, et al.
Infection|October 23, 2013
Genotypic testing on HIV-1 DNA as a tool to assess HIV-1 co-receptor usage in clinical practice: results from the DIVA study groupV Svicher, C Alteri, M Montano, et al.
Pageof 9